Demographic characteristics and respiratory symptoms of all screened subjects into three exposure categories and available data on exposure class (values are mean (SEM) or percentages)
| Category I (<2.0) | Category II (2–5) mg/m3 | Category III (>5 mg/m3) | Total | |
|---|---|---|---|---|
| *p<0.05, ANOVA least SD v the two other categories; †p<0.05, ANOVA least SD v one other category; ‡p<0.001 ANOVA, v men; §p<0.05, Kolmogorov-Smirnov v distribution in men. | ||||
| Men | 243 | 182 | 71 | 496 |
| Age (y) | 31.70 (0.42) | 32.14 (0.51) | 27.72 (0.68)* | 31.15 (0.30) |
| Length (cm) | 162.0 (0.40) | 161.1 (0.41) | 161.3 (0.7) | 161.5 (0.27) |
| Weight (kg) | 57.0 (0.53)* | 55.0 (0.6) | 54.5 (0.8) | 55.9 (0.37) |
| Smoking (%) | 51.0 | 50.5 | 46.4 | 50.0 |
| Employment (y) | 10.43 (0.34) | 10.13 (0.41) | 5.93 (0.54)* | 9.68 (0.25) |
| Cumulative exposure (mg/m3.y) | 15.65 (0.53)* | 35.45 (1.43) | 35.57 (3.22) | 26.09 (0.89) |
| Glue (%) | 42.0† | 56.6 | 50.7 | 49.0 |
| Cough (%) | 21.3 | 28.0 | 19.7 | 23.5 |
| Bronchitis (%) | 4.9 | 3.4 | 1.4 | 3.9 |
| Shortness of breath (%) | 3.3 | 5.0 | 4.3 | 4.1 |
| Wheezing (%) | 1.2 | 1.7 | 2.8 | 1.6 |
| Women | 329 | 89 | 16 | 434 |
| Age (y) | 28.91 (0.31) | 28.16 (0.54) | 27.38 (1.49) | 28.70 (0.27)‡ |
| Length (cm) | 150.80 (0.28) | 150.4 (0.6) | 151.1 (1.5) | 150.72 (0.25)‡ |
| Weight (kg) | 50.28 (0.47) | 49.8 (0.8) | 49.9 (1.6) | 50.16 (0.39)‡ |
| Smoking (%) | 0.6 | 0 | 6.3* | 6.9§ |
| Employment (y) | 8.36 (0.28)† | 7.27 (0.47)† | 5.81 (0.80)† | 8.04 (0.24)‡ |
| Cumulative exposure (mg/m3.y) | 11.48 (0.45)* | 25.45 (1.66)† | 34.87 (4.78)† | 15.47 (0.63)‡ |
| Glue (%) | 60.0 | 49.0 | 30.0 | 57.0§ |
| Cough (%) | 23.6 | 18.0 | 18.8 | 22.3 |
| Bronchitis (%) | 3.7 | 6.7 | 6.3 | 4.4 |
| Shortness of breath (%) | 3.7 | 3.4 | 6.3 | 3.7 |
| Wheezing (%) | 1.2 | 2.2 | 12.5 | 1.8 |